Ethical standards key to CEE CRO sector growth, says EastHorn

By Gareth Macdonald

- Last updated on GMT

Related tags: Clinical trials, Health care, Europe

Ethical standards key to CEE CRO sector growth, says EastHorn
Malgorzata Szerszeniewska, CEO of Central and Eastern Europe’s (CEE) “newest” CRO EastHorn, says maintaining ethical standards is crucial to sustaining the rapid patient recruitment rates that characterise the region.

Szerszeniewska, who oversaw the EastHorn relaunch yesterday after the firm changed its name from Unimed, told Outsourcing-pharma just why the local CRO sector has grown so rapidly in recent years.

She explained that: “The success of clinical trials in Central and Eastern Europe has been a result of the underinvested health care systems and will continue as long as economies of these countries are far behind Western World.

There are still difficulties in receiving healthcare in CEE, therefore the willingness to partake in trials and the attitude of patients is such that high recruitment and low drop out rates will continue for the foreseeable future​.”

She added that: “We are beginning to see saturation in the countries with the longest experience in clinical trials like Poland, Hungary, and Czech Republic but there is still plenty of potential; particularly in the former Russian Republics and the Balkans for untapped patient resources.

We may expect some difficulties with patient recruitment in some countries but it is mostly related to the bad press clinical trials have there. That is why it is crucial to maintain the highest ethical standards and respect to the patient’s rights while running clinical trials in CEE​.”

Personal response

Szerszeniewska was also confident that EastHorn will be able to compete with larger CROs operating in the CRO.

Many research companies prefer to deal with smaller companies, with management and key decisions makers based in the place where trials are conducted as they feel that they get a more personal response and due to lower overheads better value for money.

She went on to say that that EastHorn is planning further expansion in the region as well as furthering its access to emerging CRO markets in Turkey, Africa and China.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us

Products

View more

Webinars